Table 3.

“At Least Slightly Better” and “At Least Better Response” Status in Clinical Global Impression of Change in Premature Ejaculation by Study Visit (Subgroups by Dosage)

	Dosage 1 = 30 mg (n = 141)	Dosage 2 = 30 → 60 mg (n = 124)	Dosage 3 = 30 → 60 → 30 mg (n = 13)	Total (n = 281)	P value
Visit 3 (week 4)
At least “slightly better,” n (%)	97 (87.39)	80 (65.04)	11 (84.62)	188 (76.11)	.0003
95% CI	79.74–92.93	55.92–73.42	54.55–98.08	70.30–81.29
At least “better,” n (%)	51 (45.95)	24 (19.51)	4 (30.77)	79 (31.98)	<.0001
95% CI	36.45–55.67	12.92–27.63	9.09–61.43	26.21–38.19
No change or worse, n (%)	14 (12.61)	43 (34.96)	2 (15.38)	59 (23.89)
Visit 4 (week 8)
At least slightly “better,” n (%)	102 (91.89)	111 (89.52)	12 (92.31)	225 (90.73)	.8058
95% CI	85.17–96.23	82.74–94.30	63.97–99.81	86.41–94.03
At least “better,” n (%)	56 (50.45)	43 (34.68)	5 (38.46)	104 (41.94)	.0491
95% CI	40.80–60.08	26.36–43.75	13.86–68.42	35.72–48.34
No change or worse, n (%)	9 (8.11)	13 (10.48)	1 (7.69)	23 (9.27)
Visit 5 (week 12)
At least “slightly better,” n (%)	109 (90.83)	107 (86.29)	12 (92.31)	228 (88.72)	.4896
95% CI	84.19,95.33	78.96–91.81	63.97–99.81	84.20–92.31
At least “better,” n (%)	68 (56.67)	62 (50.00)	4 (30.77)	134 (52.14)	.1671
95% CI	47.31–65.68	40.89–59.11	9.09–61.43	45.84–58.39
No change or worse, n (%)	11 (9.17)	17 (13.71)	1 (7.69)	29 (11.28)